Lexicon Pharmaceuticals Has Multiple Paths To Upside, But Formidable Hurdles As Well

The Lexicon Pharmaceuticals, Inc. ( LXRX ) story has had quite a few twists and turns over the years, but arguably the one constant has been that this tiny biotech can produce drugs that deliver encouragingAnalyst’s Disclosure:I/we have a beneficial long position in the shares of LXRX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relations ...